2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$56.30+$0.40 (+0.71%)
Price as of Jun 23, 2026 11:57 AM EDT- $10.8BMarket Cap
- 3.37%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$56.30+$0.40 (+0.71%)
Earnings Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -9.44% | ||
12-Month Momentum | -8.73% | ||
3-Month Risk Adjusted Momentum | -79.26% | ||
12-Month Risk Adjusted Momentum | -27.58% |
True Yield
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.13% | ||
Net Debt Paydown Yield | -7.58% |
Financial Health Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |